A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The discovery could lead to a new treatment for millions of people with both ...
Powdered ginger rhizome 940 mg was compared with oral dimenhydrinate 100 mg and with placebo in 36 male and female undergraduates who reported a high susceptibility to motion sickness. Ginger was ...
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.
Published Just now A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The discovery could lead to a new treatment for millions of ...